Microfluidics

About us

The 5th International Conference on Microfluidics, scheduled for August 27–28, 2026, in Berlin, Germany, serves as a global platform dedicated to advancing the science, engineering, and real-world applications of microfluidic technologies. Built around the theme “Engineering Miniature Fluid Worlds for Breakthroughs in Diagnostics, Therapeutics, and Bioengineering,” this conference unites leading researchers, innovators, industry experts, clinicians, engineers, and technology developers to explore the groundbreaking potential of micro-scale fluid manipulation. The event emphasizes cutting-edge advancements in lab-on-a-chip devices, organ-on-chip systems, single-cell analysis, biosensors, nano-biotechnology, point-of-care diagnostics, and microfabrication techniques that are shaping the next era of precision healthcare and biomedical innovation. The conference provides a dynamic environment for discussing challenges, exchanging ideas, showcasing high-impact research, and demonstrating next-generation tools accelerating scientific discovery. Participants gain opportunities to learn from globally renowned experts, engage in interactive sessions, and build collaborations that drive microfluidics from fundamental research toward scalable clinical, industrial, and environmental applications. With microfluidics emerging as a cornerstone of early disease detection, drug delivery optimization, regenerative medicine, and personalized therapy development, this conference aims to foster innovation that directly impacts global health and technological progress.

By bringing together multi-disciplinary perspectives, the 5th International Conference on Microfluidics stands as a catalyst for transformative solutions, empowering attendees to shape the future of diagnostics, therapeutics, and bioengineering on a global scale.

Sessions

Lab-on-a-Chip Innovations

Lab-on-a-chip innovations continue to transform how biological and chemical analyses are conducted by integrating laboratory functions into miniaturized, highly efficient platforms. These systems enable rapid sample processing, enhanced sensitivity, and reduced reagent consumption, making them valuable for clinical diagnostics, pharmaceutical screening, and environmental monitoring. Advancements in microchannel design, integrated sensors, and multiplexed detection are expanding the analytical capabilities of these devices, allowing complex workflows such as PCR, immunoassays, and pathogen detection to be executed on a single chip. Emerging materials, hybrid fabrication methods, and portable detection modules are supporting the development of low-cost, field-ready devices for global health and resource-limited settings. The integration of microfluidics with digital interfaces and automated control systems further enhances precision, throughput, and decision-making in real time. With ongoing innovations enabling faster diagnostics, personalized medicine, and decentralized testing, lab-on-a-chip technologies are positioned to influence a wide range of scientific, medical, and industrial applications.

Organ-on-Chip Engineering

Organ-on-chip engineering represents a major breakthrough in modeling human physiology by recreating organ-specific microenvironments within microfluidic systems. These platforms simulate tissue–tissue interfaces, biomechanical cues, and fluid transport, allowing realistic assessment of drug responses, toxicity profiles, and disease mechanisms. Continuous improvements in biomaterials, microchannel architectures, and dynamic flow control help mimic the structural and functional properties of organs such as the lung, liver, heart, and intestine. Integration with stem cell–derived organoids and patient-specific cells enhances predictive accuracy, supporting the development of personalized therapies and reducing dependence on animal models. Multi-organ chip systems further advance understanding of systemic interactions, pharmacokinetics, and multi-tissue communication. Data generated from these platforms accelerate drug discovery, safety assessment, and mechanistic research in ways previously unattainable through conventional methods. As organ-on-chip devices gain regulatory recognition and commercial viability, they are emerging as essential tools for biomedical research and translational science.

Point-of-Care Microdevices

Point-of-care microdevices are redefining healthcare accessibility by enabling rapid, accurate, and portable diagnostic testing directly at the patient’s location. These compact systems harness microfluidic principles to manage small volumes of biological samples, improving testing efficiency while minimizing user complexity. Integration of biosensors, lateral flow components, and multiplex microchannels allows detection of infectious diseases, metabolic conditions, and biomarkers within minutes. Recent innovations focus on smartphone-based readouts, low-power electronics, and disposable cartridges that support decentralized testing in both clinical and remote settings. Enhanced sensitivity, simplified reagent handling, and automated operation help reduce human error and ensure consistent performance. These advancements support early diagnosis, continuous monitoring, and informed clinical decisions, particularly in emergency care, rural healthcare, and global health initiatives. As demand for fast, affordable diagnostics grows, point-of-care microdevices continue to expand into new medical and non-medical fields, strengthening real-time decision-making and patient outcomes.

Single-Cell Microfluidic Analysis

Single-cell microfluidic analysis enables precise investigation of individual cellular behaviors, functions, and molecular signatures by isolating and analyzing cells at micro-scale resolution. Microfluidic systems provide controlled environments for capturing, sorting, and stimulating cells while preserving their viability and native characteristics. These technologies support high-throughput transcriptomics, proteomics, and metabolomics, revealing cellular heterogeneity that influences disease progression, immune responses, and therapeutic resistance. Innovations in droplet microfluidics, hydrodynamic traps, integrated sensors, and nanofluidic interfaces further enhance accuracy and throughput. Single-cell studies powered by microfluidics accelerate the development of personalized treatments by identifying rare cell populations, tracking cell lineage, and evaluating drug effects at unprecedented precision. Applications extend across cancer biology, immunology, regenerative medicine, and developmental biology. As techniques evolve, the ability to run thousands of single-cell assays within compact platforms positions microfluidic analysis as a cornerstone of advanced biomedical research and precision healthcare.

Droplet-Based Microfluidics

Droplet-based microfluidics manipulates discrete fluid droplets within immiscible phases, enabling highly controlled biochemical reactions in miniaturized volumes. Each droplet acts as an independent microreactor, facilitating parallel processing for applications such as high-throughput screening, digital PCR, enzymatic assays, and directed evolution. Advances in droplet generation, merging, splitting, and sorting technologies allow precise control of reaction conditions and reagent distribution. The compartmentalized nature of droplets enhances sensitivity, reduces contamination, and supports rapid analysis. Emerging innovations involve integrating optical detection, acoustic manipulation, and electric-field-based control to refine droplet dynamics. This platform is increasingly used in drug discovery, disease diagnostics, synthetic biology, and material science. With its ability to perform millions of rapid, reproducible reactions using extremely small volumes, droplet-based microfluidics accelerates discovery processes while lowering costs. Its versatility and scalability make it a powerful technology for next-generation analytical and biological workflows.

Microfabrication & Soft Lithography

Microfabrication and soft lithography provide the foundational techniques used to design and construct microfluidic devices with precise geometries and functional structures. Soft lithography using materials like PDMS offers flexibility, biocompatibility, and rapid prototyping capabilities, enabling researchers to create complex microchannel networks and integrated components. Photolithography, etching, and molding techniques support the development of high-resolution features essential for fluid manipulation and microscale control. Continuous advancements in materials science, including hybrid polymers, hydrogels, and elastomers, improve mechanical performance, chemical stability, and biological compatibility. Integration with 3D printing, nanoimprinting, and multi-layer bonding further expands design possibilities. Microfabrication techniques are central to producing devices for diagnostics, organ-on-chip systems, biosensing, and chemical analysis. As fabrication becomes more accessible and scalable, microfluidic technologies increasingly transition from research prototypes to commercially viable products used in clinics, laboratories, and industry.

Microfluidic Biosensors & Diagnostics

Microfluidic biosensors and diagnostics combine sensitive biorecognition elements with fluidic control to deliver rapid, accurate, and miniaturized detection systems. These platforms integrate optical, electrochemical, and mechanical sensing mechanisms to identify biomarkers, pathogens, and molecular targets using minimal sample volumes. Advances in surface functionalization, nano-enabled sensing materials, and integrated signal amplification enhance sensitivity, allowing early disease detection and real-time monitoring. Compact cartridge-based systems enable multiplex assays for a wide range of clinical and environmental applications. Emerging innovations incorporate wireless connectivity, portable readers, and automated fluid handling for point-of-care and home-based diagnostics. The merging of microfluidics with AI-driven analytical algorithms supports predictive diagnostics and personalized health insights. As global demand for rapid, reliable testing grows, microfluidic biosensors continue to expand their impact across medical diagnostics, food safety, environmental monitoring, and biothreat detection.

Nanofluidics & Molecular Transport

Nanofluidics explores fluid behavior and molecular transport within nanoscale channels, where unique physical phenomena emerge and traditional fluid dynamics no longer apply. These confined environments allow precise manipulation of ions, biomolecules, and nanoparticles, enabling advanced sensing, molecular filtration, and sequencing technologies. Innovations in nanotube integration, graphene membranes, and solid-state nanopores support high-resolution studies of DNA, proteins, and metabolites. Nanofluidic systems contribute to ultra-sensitive detection of rare biomarkers, energy-efficient desalination, and controlled drug release. Understanding molecular interactions at the nanoscale provides insights into biological processes and supports the development of next-generation analytical tools. As fabrication techniques advance, the ability to reliably engineer nanoscale channels improves device reproducibility and commercial potential. Nanofluidics continues to push boundaries in biotechnology, chemistry, and materials science by enabling unprecedented control of molecular-scale transport.

Microfluidics for Drug Delivery

Microfluidics for drug delivery focuses on designing precise, controlled systems that improve how therapeutic agents are formulated, encapsulated, and delivered within the body. These platforms enable production of uniform nanoparticles, liposomes, micelles, and drug-loaded droplets tailored for targeted release. Microfluidic reactors provide predictable mixing, rapid formulation screening, and enhanced scalability compared to traditional methods. Integration with stimuli-responsive materials allows triggered release based on pH, temperature, or biochemical cues. Microfluidic-assisted drug delivery supports personalized medicine by enabling patient-specific dosing, reduced toxicity, and enhanced therapeutic efficacy. Its applications extend across oncology, immunotherapy, vaccine development, and regenerative medicine. As pharmaceutical industries seek highly reproducible, efficient, and customizable formulation technologies, microfluidic approaches continue to strengthen their role in modern drug development pipelines.

3D Printing in Microfluidics

3D printing in microfluidics unlocks new possibilities for designing and manufacturing complex fluidic architectures with rapid iteration and cost-effective production. Additive manufacturing enables fabrication of intricate microchannel networks, integrated valves, sensors, and multi-material components that are difficult to achieve with traditional lithography. Advances in high-resolution printing techniques, such as two-photon polymerization and resin-based stereolithography, support sub-micron accuracy and smooth channel surfaces. The flexibility of 3D printing accelerates prototyping, customization, and scalability for clinical and industrial applications. Materials innovations, including biocompatible resins, elastomers, and functionalized polymers, enhance device performance and compatibility with biological systems. As 3D printing merges with microfluidic engineering, new opportunities emerge for creating wearable systems, organ-on-chip platforms, and modular diagnostic devices that can be tailored to specific research or clinical needs.

Microfluidic Cell Culture Platforms

Microfluidic cell culture platforms replicate physiological microenvironments by controlling nutrient flow, shear stress, and chemical gradients at microscale precision. These systems support long-term culture of cells, tissues, and organoids, enabling detailed study of cellular behavior, drug responses, and disease mechanisms. Integration of real-time imaging, embedded sensors, and 3D extracellular matrices enhances monitoring and functionality. Controlled microenvironments promote reproducibility, reduce reagent use, and allow high-throughput experimentation. Applications span cancer research, immunology, neuroscience, and regenerative medicine. As cell-based models evolve, microfluidic culture systems provide more accurate, dynamic, and physiologically relevant platforms than conventional static cultures. Continued innovation is driving their adoption in pharmaceutical testing, toxicology studies, and personalized medicine development.

AI & Automation in Microfluidic Systems

AI and automation in microfluidic systems enhance experimental precision, throughput, and decision-making by integrating advanced analytics and autonomous control. Machine learning models optimize flow dynamics, predict reaction outcomes, and analyze complex biological data generated by microfluidic assays. Automated systems incorporate robotic handling, programmable pumps, and real-time feedback loops to reduce human error and increase reproducibility. These technologies enable high-throughput experimentation, rapid optimization of chemical reactions, and intelligent diagnostics. Artificial intelligence supports real-time image analysis, pattern recognition, and predictive modeling to accelerate scientific discovery. Automation ensures scalability, consistency, and efficiency for applications in pharmaceuticals, diagnostics, and synthetic biology. As microfluidic platforms generate increasingly complex datasets, AI-driven systems play a crucial role in transforming raw information into actionable insights and advancing next-generation microfluidic technologies.

Microreactors & Chemical Processing

Microreactors enable controlled chemical processing by confining reactions within precisely designed microchannels that enhance heat transfer, mixing, and reaction kinetics. These reactors facilitate safe handling of hazardous materials, efficient synthesis of fine chemicals, and rapid optimization of reaction conditions. Continuous-flow processing ensures high reproducibility, reduced waste, and scalable production. Innovations include multistep microreactor systems, integrated sensors, catalytic microchannel surfaces, and automated control modules. Microfluidic chemical processing supports pharmaceutical synthesis, material production, nanoparticle fabrication, and green chemistry initiatives. The precision and flexibility of microreactors accelerate reaction development and support sustainable manufacturing. With growing industrial demand for safer, faster, and more efficient chemical processes, microreactor technology continues to advance as a key component of modern chemical engineering.

Biomedical Microfluidic Applications

Biomedical microfluidic applications encompass a wide range of technologies used for diagnostics, therapeutic design, cell manipulation, and disease modeling. Microfluidics supports rapid blood analysis, immune profiling, pathogen detection, and point-of-care testing with high sensitivity and low sample requirements. Controlled microenvironments enable advanced tissue modeling, organ-on-chip systems, and targeted drug delivery strategies. Integration with biosensors, imaging systems, and data analytics improves monitoring and clinical decision-making. Microfluidic tools accelerate research in oncology, infectious diseases, cardiovascular biology, and neuroscience by enabling precise manipulation of biological samples. Advancements in device integration, material innovation, and clinical validation continue to expand the role of microfluidics in translational medicine. As healthcare shifts toward personalized, decentralized, and data-driven approaches, biomedical microfluidics remains central to developing next-generation medical solutions.

Clinical Translation & Commercialization

Clinical translation and commercialization of microfluidic technologies involve transforming laboratory innovations into reliable, scalable products that address real-world healthcare needs. Success depends on robust validation, regulatory approval, manufacturability, and user-centered design. Key considerations include material compatibility, device durability, cost-efficiency, and seamless integration with clinical workflows. Collaboration among researchers, clinicians, industry partners, and regulatory agencies accelerates product development and market readiness. Scalable manufacturing methods such as injection molding, roll-to-roll processing, and hybrid fabrication enable mass production of microfluidic devices for diagnostics, drug delivery, and monitoring solutions. Commercialization efforts increasingly emphasize digital integration, cloud-based data systems, and interoperability. As global demand for portable diagnostics, personalized therapies, and automated laboratory systems grows, microfluidic technologies continue to advance toward widespread clinical adoption, shaping the future of healthcare innovation.

Market Analysis

The global microfluidics market is experiencing rapid expansion, driven by rising demand for miniaturized diagnostic systems, advanced drug development solutions, and precision biomedical tools. Microfluidics has moved from a niche research field to a mainstream technology enabling breakthroughs in healthcare, biotechnology, pharmaceuticals, and chemical engineering. Increasing emphasis on point-of-care diagnostics, personalized medicine, and rapid disease detection continues to accelerate adoption across clinical and commercial sectors. The COVID-19 pandemic further highlighted the importance of fast, low-volume testing, leading to greater investment in lab-on-chip devices, microfluidic biosensors, and portable testing platforms. A major growth driver is the rising integration of microfluidics in drug formulation, targeted delivery, and nanoparticle synthesis. Pharmaceutical companies increasingly rely on microreactors and controlled microenvironments to achieve consistent particle size, improved encapsulation efficiency, and scalable production of complex therapeutic formulations. Organ-on-chip and single-cell analysis technologies are creating new opportunities for preclinical research, reducing reliance on animal models, and providing more accurate predictions of human responses to drugs. As regulatory agencies gain confidence in microfluidic-based testing, commercial opportunities for organ-on-chip platforms are expanding significantly. Technological advancements in microfabrication, soft lithography, nanomaterials, and 3D printing are enabling the development of more sophisticated and cost-effective devices. These innovations have lowered production barriers, allowing startups and academic laboratories to transition concepts into commercially viable solutions. Integration with artificial intelligence and automation is reshaping data processing, experimental workflows, and diagnostics. AI-driven microfluidic systems enhance decision-making, optimize reaction conditions, and support high-throughput experimentation, increasing efficiency in both clinical and industrial applications. Point-of-care diagnostics remains one of the strongest market segments, fueled by growing demand for decentralized healthcare and immediate testing solutions. Microfluidic-based devices for infectious disease detection, metabolic monitoring, and molecular diagnostics are experiencing widespread adoption due to their speed, accuracy, portability, and low sample requirements. Continued global focus on improving healthcare access in developing regions presents significant opportunities for affordable microfluidic technologies that support large-scale screening and monitoring.

The market is also benefiting from increasing use in environmental monitoring, food safety testing, and chemical analysis. Microreactors and continuous-flow processing systems are gaining traction in the chemical and materials industries because they provide safer, more efficient, and sustainable alternatives to traditional batch processing. As industries push toward green and scalable manufacturing, microfluidic systems offer a competitive advantage through improved precision and reduced waste. Despite substantial growth, the microfluidics market faces challenges such as fabrication complexity, standardization issues, and regulatory hurdles. However, advancements in mass manufacturing techniques, such as injection molding and roll-to-roll processing, are helping address scalability concerns. Strategic collaborations between academia, clinical institutions, and industry players are accelerating the commercialization pipeline. Overall, the microfluidics market is projected to continue strong growth, supported by rising healthcare demands, technological innovations, and expanding industrial applications. Its role in diagnostics, therapeutics, and bioengineering positions microfluidics as a core driver of next-generation scientific and medical advancements.

Past Conference Report

Microfluidics 2025

It is our great pleasure to welcome you to the 4th International Microfluidics Conference which is going to be held in September 15-16, 2025 Paris, France. The purpose of this conference is to provide an international technical forum to showcase recent advances in microfluidics and medical microsystems. Microfluidic devices and systems have created a tremendous interest in many application fields, including life sciences, point of care diagnostics, and environmental applications. The conference aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Microfluidics and its development.